This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tang, T. C-M. Articles by Guan, X.-Y. Search for Related Content PubMed PubMed Citation Articles by Tang, T. C-M. Articles by Guan, X.-Y.

Identification of a Candidate Oncogene SEI-1 within a Minimal Amplified Region at 19q13.1 in Ovarian Cancer Cell Lines¹

Department of Clinical Oncology, The University of Hong Kong, Hong Kong, China [T. C-M. Y., J. S. T. S., X-Y. G.]; Department of Pathology [D. X.], and Cancer Institute [Y. F., Q-L. W.], Sun Yat-Sen University, Guangzhou, China; and State Key Laboratory of Genetic Engineering, Institute of Genetics, Fudan University, Shanghai, China [K-K. H.]

High-level amplification of DNA sequence at 19q13.1 is one of the frequent genetic alterations in ovarian cancer. In an attempt to verify the minimal amplified region (MAR) at 19q13.1 and to identify the target oncogenes, 49 probes within a region from D19S425 to D19S907 (19.5 cM) were used to survey the amplification status in four ovarian cancer cell lines that have been confirmed as containing amplification at 19q13.1. Two separated overlapping MARs, MAR1 (200 kb) and MAR2 (1.1 Mb), were identified at 19q13.1. Two candidate oncogenes, AKT2 and SEI-1, were identified in MAR2. Amplification and overexpression of these two genes in four ovarian cancer cell lines were confirmed by Southern and Northern blot analyses. The proliferation-related function of AKT2 and SEI-1 suggests that both genes are likely to be biological targets of an amplification event at 19q13.1 in ovarian cancer and to play important roles in ovarian tumorigenesis.

This article has been cited by other articles:

				S. L. O. Lee, S.-W. Hong, J.-S. Shin, J. S. Kim, S.-G. Ko, N.-J. Hong, D. J. Kim, W.-J. Lee, D.-H. Jin, and M.-S. Lee p34SEI-1 Inhibits Doxorubicin-Induced Senescence through a Pathway Mediated by Protein Kinase C-{delta} and c-Jun-NH2-Kinase 1 Activation in Human Breast Cancer MCF7 Cells Mol. Cancer Res., November 1, 2009; 7(11): 1845 - 1853. [Abstract] [Full Text] [PDF]

				S.-W. Hong, C.-J. Kim, W.-S. Park, J.-S. Shin, S.-D. Lee, S.-G. Ko, S.-I. Jung, I.-C. Park, S.-K. An, W.-K. Lee, et al. p34SEI-1 Inhibits Apoptosis through the Stabilization of the X-Linked Inhibitor of Apoptosis Protein: p34SEI-1 as a Novel Target for Anti-Breast Cancer Strategies Cancer Res., February 1, 2009; 69(3): 741 - 746. [Abstract] [Full Text] [PDF]

				R. Hayashi, Y. Goto, R. Ikeda, K. K. Yokoyama, and K. Yoshida CDCA4 Is an E2F Transcription Factor Family-induced Nuclear Factor That Regulates E2F-dependent Transcriptional Activation and Cell Proliferation J. Biol. Chem., November 24, 2006; 281(47): 35633 - 35648. [Abstract] [Full Text] [PDF]

				D.-J. Tang, L. Hu, D. Xie, Q.-L. Wu, Y. Fang, Y. Zeng, J. S.T. Sham, and X.-Y. Guan Oncogenic Transformation by SEI-1 Is Associated with Chromosomal Instability Cancer Res., August 1, 2005; 65(15): 6504 - 6508. [Abstract] [Full Text] [PDF]